近3年住院患者药物性肝损伤状况调查

doi:10.3969/j.issn.1672-5069.2018.04.043

Abstract

Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.

[1] Jung KA,Min HJ,Yoo SS,et al.Drug-Induced liver Injury: twentyfive cases of acute hepatitis following ingestion of polygonum multiflorum thunb.Gut Liver,2011,5(4):493-499.
[2] 李平,谢同柄.132例药物性肝损伤临床分析. 实用肝脏病杂志,2010,13(1):48-50.
[3] 姚云洁,刘鸿凌,朱冰,等. 441例药物性肝损伤患者临床和肝组织病理学特征分析. 实用肝脏病杂志,2015,18(3):286-289.
[4] Ma KF,Zhang XG,Jia HY.CYP1A2 polymorphism in Chinese patients with acute liver injury induced by Polygonum multiflorum. Genet Mol Res,2014,13(3):5637-5643.
[5] Woo HJ,Kim HY,Choi ES,etal. Drug-induced liver injury:A 2-year retrospective study of 1169 hospitalized patients in a single medical center.Phytomedicine,2015,22(13):1201-1205.
[6] 朱雯静,赵新颜,马红,等. 慢性药物性肝损伤的研究进展.中华肝脏病杂志,2015,23(9):718-720.
[7] Wang YY,Li J,Wu ZR,et al.Insights into the molecular mechanisms of polygonum multiflorum Thunb-induced liver injury:a computational systems toxicology approach.Acta Pharmacol Sin,2017,38(5):719-732.
[8] Zhu Y,Li YG,Wang JB,et al.Causes,features,and outcomes of drug-induced liver injury in 69 children from China. Gut Liver,2015,9(4):525-533.
[9] Vuppalanchi R,Hayashi PH,Chalasani N,et al.Duloxetine hepatotoxicity:a case-series from the drug-induced liver injury network.Aliment Pharmacol Ther,2010,32(9):1174-1183.
[10] Okajima A,Yamaguchi K,Taketani H,etal. Drug-induced liver injury in a chronic hepatitis C patient treated by peginterferon,ribavirin and simeprevir.Hepatol Res,2015,45(10):E156-160.
[11] Yuen MF,Tam S,Fung J,et al.Traditional chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection:a 1-year prospective study.Aliment Pharmacol Ther,2006,24(8):1179-1186.
[12] Shah F,Leung L,Barton HA,etal. Setting clinical exposure levels of concern for drug-induced liver injury (DILI) ssing mechanistic in vitro assays.Toxicol Sci,2015,147(2):500-514.

[1]	Wu Xin, Guo Yangzhi, Du Xiaorang, et al. Clinical features of herb-induced liver injury [J]. Journal of Practical Hepatology, 2019, 22(5): 668-671.
[2]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[3]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[4]	Zhuang Taiping, Yin Yangyan, Xie Manfang, et al. Comparison of clinical features of infants with human cytomegalovirus infection and of infantile hepatitis syndrome [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 514-517.
[5]	Peng Silu, Liu Bing, Sun Hong, et al. Prognosis of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 545-548.
[6]	Zhang Tingting, Wang Xuan. Clinical implications of oral glucose tolerance test in cirrhotic patients with hepatogenous diabetes [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 449-452.
[7]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[8]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[9]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[10]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[11]	Song Fangjiao, Zhu Bing, Lyu Sa, Tian Hua, Wang Haibo, Xin Shaojie, You Shaoli. Clinical analysis of drug-induced liver failure：a report of 314 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 216-219.
[12]	Gao Pengbin, Zhao Xiaoyan, Qin Hao, Wu Fengying, Zhang Haizhen, Wang Lin, Jia Huina, Li Shujuan. Risk factors for poor prognosis of patients with hepatitis E-induced liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 220-223.
[13]	Wang Huming, Fan Dongsheng, Xu Jie, Liu Xianfegn, Zhou Ning, Li Min, Bao Nana. Cancerous miRNA-30c levels affecting the survival of patients with hepatocellular carcinoma after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 248-251.
[14]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[15]	Ma Hulin, Sun Xiaoxia, Gao Weishi. Angiomyolipoma of the liver: one case report [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 291-292.

Analysis of patients with drug-induced liver injury in recent 3 years

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments